Showing results (31-40 of 291) with videos related to
Sort By:
Pageof 30
Frontiers in Pharmacology|January 24, 2020
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple SclerosisStéphanie Hostenbach, Miguel D'Haeseleer, Ron Kooijman, et al.Neurotoxicology|August 7, 2010
Delayed akinetic catatonic mutism following methadone overdoseSarah Gheuens, Alex Michotte, Anja Flamez, et al.Progress in Neurobiology|May 3, 2016
The pathophysiological role of astrocytic endothelin-1Stéphanie Hostenbach, Miguel D'haeseleer, Ron Kooijman, et al.Journal of Neurochemistry|March 14, 2007
Enhanced proliferation of astrocytes from beta(2)-adrenergic receptor knockout mice is influenced by the IGF systemDaniel Chesik, Lisa Glazenburg, Jacques De Keyser, et al.Acta Neurologica Belgica|July 24, 2017
Role of infarct location and pre-existing depression on cardiac baroreceptor sensitivity in subacute ischemic strokeAurelie De Vos, Jacques De Keyser, Sylvie De RaedtJournal of the Neurological Sciences|December 27, 2014
Autonomic dysfunction in acute ischemic stroke: an underexplored therapeutic area?Sylvie De Raedt, Aurelie De Vos, Jacques De KeyserThe Lancet. Neurology|June 21, 2011
Vascular aspects of multiple sclerosisMiguel D'haeseleer, Melissa Cambron, Ludo Vanopdenbosch, et al.Journal of the Neurological Sciences|October 16, 2007
Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disordersJacques De Keyser, Jop P Mostert, Marcus W KochTrends in Pharmacological Sciences|April 23, 2004
Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosisJacques De Keyser, Esther Zeinstra, Jop Mostert, et al.Neurochemistry International|May 13, 2008
IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelinationNadine Wilczak, Daniel Chesik, Dick Hoekstra, et al.Pageof 30